US
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
US | 23 May 2012
-
US Supreme Court clears way for generic patent challenges
After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.
US | 18 May 2012
-
Anti-trust authorities approve Bosch’s acquisition of Eisai Machinery
Bosch finalized the acquisition of the machinery business companies of Eisai, one of the leading Japanese pharmaceutical companies based in Tokyo. The transaction has been approved by the antitrust authorities without further restrictions.
US | 14 May 2012
-
Telormedix’s TMX-101 exhibits high safety in phase I/II for non-muscle invasive bladder cancer
Telormedix announced that it has successfully completed the safety portion of a Phase I/II trial for TMX-101.
US | 04 May 2012
-
INCIVEK is well tolerated with commonly used Atripla- and Reyataz-based HIV treatment regimens
Phase 2 study of INCIVEK combination regimen shows 74 percent of people co-infected with hepatitis C, HIV had undetectable hepatitis C virus 12 weeks after treatment ended.
US | 30 April 2012
-
Erasmus Medical Center selects Agilent solutions
Agilent Technologies announced that Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders.
US | 23 April 2012
-
Quintiles, Biofund to expand clinical development capabilities in Russia
Russian venture company (RVC), Biofund, and Quintiles announced an agreement to support expansion of clinical development services within the Russian Federation, the world’s ninth most populous country.
US | 13 April 2012
-
US FDA grants priority review to Bayer’s Xarelto
Bayer, together with its cooperation partner, Janssen Research & Development, announced that the US FDA has granted priority review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for the oral anticoagulant Xarelto.
US | 09 April 2012
-
GEA Pharma appoints director of sales, business development for Latin America
GEA Pharma Systems has appointed Zósimo López Moreno as its director sales and business development for Latin America.
US | 22 March 2012
-
Vietnam will continue to rely heavily on pharmaceutical imports
Despite strong growth potential, the government's protectionist policy of preventing foreign owned companies from distributing their products and other regulatory inefficiencies will continue to hinder the development of the pharmaceutical sector in the country.
US | 16 March 2012
